Seppe Vander Beken

Publication Activity (10 Years)

Years Active: 2022-2022
Publications (10 Years): 5

Top Topics

Hodgkin Lymphoma

Neuropathic Pain

Top Venues

Antioxidants (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Carmen Salinas-Gilabert, Francisco José Gómez García, Fe Galera Molero, Eduardo Pons-Fuster, Seppe Vander Beken, López-Jornet Pia
Photodynamic Therapy, Photobiomodulation and Acetonide Triamcinolone 0.1% in the Treatment of Oral Lichen Planus: A Randomized Clinical Trial. Pharmaceutics 15 (1) (2022)
Carmen Salinas-Gilabert, Francisco José Gómez García, Fe Galera Molero, Eduardo Pons-Fuster, Seppe Vander Beken, López-Jornet Pia
Photodynamic Therapy, Photobiomodulation and Acetonide Triamcinolone 0.1% in the Treatment of Oral Lichen Planus: A Randomized Clinical Trial. Pharmaceutics 15 (1) (2022)
Reem Hanna, René-Jean Bensadoun, Seppe Vander Beken, Patricia Burton, James Carroll, Stefano Benedicenti
Outpatient Oral Neuropathic Pain Management with Photobiomodulation Therapy: A Prospective Analgesic Pharmacotherapy-Paralleled Feasibility Trial. Antioxidants (Basel, Switzerland) 11 (3) (2022)
Carmen Salinas-Gilabert, Francisco José Gómez García, Fe Galera Molero, Eduardo Pons-Fuster, Seppe Vander Beken, López-Jornet Pia
Photodynamic Therapy, Photobiomodulation and Acetonide Triamcinolone 0.1% in the Treatment of Oral Lichen Planus: A Randomized Clinical Trial. Pharmaceutics 15 (1) (2022)
Carmen Salinas-Gilabert, Francisco José Gómez García, Fe Galera Molero, Eduardo Pons-Fuster, Seppe Vander Beken, López-Jornet Pia
Photodynamic Therapy, Photobiomodulation and Acetonide Triamcinolone 0.1% in the Treatment of Oral Lichen Planus: A Randomized Clinical Trial. Pharmaceutics 15 (1) (2022)